Fentanyl has driven the deadliest drug crisis in American history. In the decade from 2013 to 2023, synthetic opioid overdose deaths rose more than twentyfold, from about 3,100 a year to more than 72,000. There are signs of progress: deaths began falling in 2023 and dropped sharply in 2024. But the scale of the crisis remains staggering, and understanding where the numbers stand today is essential context for anyone working in addiction treatment or trying to understand what happened to someone they love.
The Scale of Fentanyl Overdose Deaths
Fentanyl-involved overdose deaths began rising sharply in 2013, the start of what the CDC calls the third wave of the opioid epidemic. According to USAFacts analysis of CDC data, deaths involving synthetic opioids other than methadone (primarily illicitly manufactured fentanyl) rose from 3,105 in 2013 to 72,776 in 2023, an increase of more than 23 times in roughly a decade.
The most recent finalized data shows a significant decline. According to the CDC’s NCHS Data Brief on drug overdose deaths in 2023-2024, the drug overdose death rate fell from 31.3 per 100,000 people in 2023 to 23.1 in 2024, a 26.2% decrease, the largest single-year drop in the 2014-2024 period. Deaths involving synthetic opioids declined the most of any opioid type, falling 35.6% in rate. Provisional data indicates the downward trend has continued into 2025.
This decline represents tens of thousands of lives, but it is not a resolution. Even after the drop, fentanyl remains the dominant driver of overdose mortality in the United States, and overdose remains the leading cause of death for Americans aged 18 to 44.
Fentanyl’s Share of the Overdose Crisis
The degree to which fentanyl has come to dominate overdose deaths is striking. As the CDC reports, in 2023 about 69% of all drug overdose deaths involved synthetic opioids, primarily illicitly manufactured fentanyl. That same year, synthetic opioids were involved in nearly 92% of all opioid overdose deaths, meaning fentanyl, not prescription opioids or heroin, now drives the opioid crisis.
Fentanyl’s reach also extends into deaths involving other drugs. According to NIDA, the share of heroin-involved overdose deaths that also involved illicitly manufactured fentanyl rose to 80% in 2022 and remained high through 2023. Nearly 70% of stimulant-involved overdose deaths in 2023 also involved fentanyl, as did nearly 70% of benzodiazepine-involved overdose deaths that year. Because fentanyl has so thoroughly saturated the illicit drug supply, often pressed into counterfeit pills or mixed into other drugs, overdose risk is increasingly tied to fentanyl rather than to whichever drug a person believes they are using.
Who Is Most Affected: Demographics
Fentanyl overdose deaths are not evenly distributed. Analysis of CDC data by USAFacts shows that in 2023, adults aged 35-44 accounted for the largest share of fentanyl overdose deaths at 28%, followed by adults aged 25-34 at 23%. Together, these two age groups made up roughly 27% of the U.S. population but accounted for over half of all fentanyl overdose deaths.
Fentanyl overdose mortality also varies sharply by race and ethnicity. In 2023, fentanyl overdose death rates were highest among Black Americans (35.0 per 100,000) and American Indian or Alaska Native people (28.5), both well above the rate for White Americans (21.9) and the national average of 22.2. These gaps mark a shift from earlier in the epidemic, when overdose rates were highest among White Americans. American Indian and Alaska Native people have also experienced the highest rates of fentanyl-involved nonfatal overdose emergency department visits, along with the largest quarterly increases, from late 2020 through mid-2023.
Geographic Variation
Fentanyl overdose deaths are geographically concentrated but have spread nationwide. In 2023, West Virginia reported the highest fentanyl overdose death rate in the country at 69.2 per 100,000 people, while Nebraska had the lowest at 3.3. Because more populous states record more total deaths, the highest death counts that year were in California (7,203), New York (4,936), and Florida (4,593), reflecting population size as much as rate.
The broader trend points downward. According to KFF’s analysis of opioid overdose deaths, opioid overdose death rates fell in every state from 2023 to 2024, with the largest declines in Virginia, Wisconsin, and West Virginia (each down roughly 44 to 46%). Even so, about half of states remained above their pre-pandemic 2019 levels in 2024, and Alaska and Oregon saw the largest increases relative to 2019. The uneven timing of fentanyl’s spread, generally moving east to west, helps explain why states are at such different points in the trend.
Seizure Data and Fentanyl in the Supply
Law enforcement data offers a parallel picture of fentanyl’s spread. The DEA has seized fentanyl-xylazine mixtures in 48 of 50 states, and its 2023 laboratory testing found that seven of every 10 fentanyl-laced counterfeit pills contained a potentially lethal dose, up from four in 10 in 2021 and six in 10 in 2022.
This seizure data lines up with the mortality data: fentanyl is no longer confined to particular regions or drug markets but has spread across the country’s illicit drug supply. As NIDA’s overdose data shows, illicitly manufactured fentanyl is now frequently involved in deaths attributed to prescription opioids, heroin, cocaine, methamphetamine, and benzodiazepines alike.
Context: The Decline Is Real, but the Crisis Is Not Over
The recent drop in fentanyl-involved overdose deaths marks the first sustained decline in years, following the first annual decrease since 2018. Provisional data projecting continued declines through 2025 suggests the downward trend has real momentum. While no single cause explains the turnaround, KFF notes that expanded access to treatment and overdose-reversal drugs such as naloxone, along with public awareness efforts, may all have contributed.
At the same time, the numbers remain staggering in absolute terms. CDC data shows that roughly 54,000 Americans died from opioid overdoses in 2024. The treatment gap also remains enormous: in 2023, an estimated 54.2 million Americans aged 12 and older needed substance use disorder treatment, but only 12.8 million received it. The data shows progress, but the crisis is not over.
Professional Perspective: Fentanyl Statistics & Data
The statistics on fentanyl mortality show a major change in the clinical and public health picture of opioid use disorder. Fentanyl now accounts for the overwhelming majority of opioid overdose deaths and drives the clinical picture of opioid use disorder. The demographic data reveals that the populations most affected have shifted over time, and that disparities by race and geography persist even as overall numbers have begun to decline.
“EDs [emergency departments] are critical locations for implementing strategies that might prevent future or repeat fentanyl-involved overdoses among patients with substance use disorder, with a history of drug use, or who experienced a recent nonfatal overdose, particularly among those persons for whom an ED is the primary contact with the health care system. EDs can introduce overdose prevention strategies, initiate treatment, and link persons who have opioid use disorder to care.”
For treatment programs and clinicians, the data has direct operational implications. The populations showing the least improvement, including American Indian and Alaska Native people, Black non-Hispanic adults, and older adults, are where expanded treatment access and harm reduction need to be prioritized. The decline in deaths has not reduced demand for treatment. More people are surviving long enough to need it.
The Numbers Behind the Crisis
The decline in fentanyl overdose deaths is the first real sign of progress in years, and it matters. But progress is not the same as resolution. Behind every statistic on this page is a person and a family changed by this crisis. The treatment gap remains the most important number of all: millions of people who could benefit from effective care are not receiving it. That is the problem the data points to, and closing it is what the next chapter of this crisis depends on.